Lidocaine HCl Injection USP recall — Spectra Medical Devices, LLC (Class II)

Spectra Medical Devices, LLC is recorded by the U.S. Food and Drug Administration (FDA) as recalling Lidocaine HCl Injection USP — a Class II recall, initiated 2026-05-12 and posted to the FDA enforcement report on 2026-06-10, under recall number D-0554-2026. Status Ongoing, with no termination date on the record. The reason the FDA record carries is, verbatim: “Lack of Assurance of Sterility”. From the product description, the form is injection and it is marked Rx only. 1 National Drug Code number is printed in the record: 65282-1605-1. Distribution is recorded as “USA Nationwide” — Nationwide (US), with the recalling firm on record in MA, United States. It is the only recall number the FDA has filed under event ID 98976. 4 indexed records name lidocaine hydrochloride as the recalled substance. Values are reproduced from the linked openFDA report; regulatory information, not medical advice.

Regulatory snapshot

Recall number D-0554-2026
FDA event ID 98976
Classification Class II (intermediate regulatory tier)
Status Ongoing
Recalling firm Spectra Medical Devices, LLC
Recall initiated 2026-05-12
Reported by FDA 2026-06-10
Report lag 29 days from initiation to report
Distribution USA Nationwide — Nationwide (US)
Firm location on record MA, United States
Product description (source) Lidocaine HCl Injection USP, 25x5 mL, Single-Dose Ampules, Rx Only, Distributed by: Spectra Medical Devices, LLC, Wilmington, Made in S. Korea, NDC 65282-1605-1.

Reason reported by FDA

Lack of Assurance of Sterility

5 words from the enforcement report field reason_for_recall, reproduced without edit — the firm's own wording, not an assessment.

Product identifiers in this record

5 identifying values matched by exact pattern in the 23-word product description above; each is a literal substring of it.

Product named Lidocaine HCl Injection USP
Form Injection
NDC 65282-1605-1
Marketing category Rx only
Stated origin S. Korea
Distributed by Spectra Medical Devices, LLC

Other indexed recalls of lidocaine hydrochloride

4 indexed records name lidocaine hydrochloride as the recalled substance. Matching is on the product-name prefix of the FDA's own text, so other strengths and packages are included.

Recall recordRecall numberRecalling firmStrength / formReported
Lidocaine HCl Injection, 2%D-0726-2026Fresenius Kabi Usa, LLC2% · Injection2026-07-29
Lidocaine HCl Injection USP, 1%D-0659-2026Asclemed Usa Inc.1% · Injection2026-07-08
Lidocaine HCl Injection, 2%D-0552-2026Eugia US LLC2% · Injection2026-06-10

Reported in the same month (2026-06)

74 enforcement reports carry a report date in 2026-06; these 8 are the Class II ones nearest this record.

Recall recordRecall numberRecalling firmFDA tierReported
Duloxetine DR Capsules, 30 mgD-0555-2026Asclemed Usa Inc.Class II2026-06-10
Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mgD-0556-2026Ascend Laboratories, LLCClass II2026-06-10
KIRKLAND Signature, 1000 mgD-0557-2026Guardian Drug Co. Inc.Class II2026-06-10
HALEON CALCIUM CARBONATE TUMS ANTACID, 1000 mgD-0558-2026Guardian Drug Co. Inc.Class II2026-06-10
HALEON CALCIUM CARBONATE TUMS ANTACID, 750 mgD-0559-2026Guardian Drug Co. Inc.Class II2026-06-10
Good Neighbor Pharmacy, 750 mgD-0560-2026Guardian Drug Co. Inc.Class II2026-06-10
Good Neighbor Pharmacy, 1000 mgD-0561-2026Guardian Drug Co. Inc.Class II2026-06-10
Extra strength Antacid Calcium Carbonate 750 mgD-0562-2026Guardian Drug Co. Inc.Class II2026-06-10

Nearest Class II recalls by date

213 of 250 indexed records share the Class II tier; the 5 nearest to 2026-06-10 by report date are listed here.

Recall recordRecall numberRecalling firmStrength / formReported
24/7 life BY 7-ELEVEND-0563-2026Guardian Drug Co. Inc.7 l · Chewable Tablets2026-06-10
MARKET BASKET ANTACID Calcium Carbonate 1000 mgD-0564-2026Guardian Drug Co. Inc.1000 mg · Tablets2026-06-10
CAREone, 750 mgD-0565-2026Guardian Drug Co. Inc.750 mg · Chewable Tablets2026-06-10
CAREone, 1000 mgD-0566-2026Guardian Drug Co. Inc.1000 mg · Chewable Tablets2026-06-10
DISCOUNT drug mart, 750 mgD-0567-2026Guardian Drug Co. Inc.750 mg · Tablets2026-06-10

Reading this record

Class II is the FDA's own severity tier for the recall action — 213 of the 250 indexed records carry it — and it describes the agency's assessment of the action, not a risk statement about any individual. Match a package against 65282-1605-1 at the FDA source to confirm it is covered.

Namespace context: the Class II index (213 records) and the recall hub (250 records, 118 FDA events); Spectra Medical Devices, LLC (1 indexed records) aggregates this firm across datasets.

Coverage and limits of this record

This page reflects the openFDA enforcement report for D-0554-2026 as ingested on 2026-08-22, which can lag the live FDA record and omits detail held only in primary documents. It offers no clinical assessment, no advice about whether to use any product, and no substitute. For any health question consult a qualified healthcare professional.

Source & provenance

Official source
https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0554-2026%22
Source dataset
openFDA Drug Enforcement API
Publication date
2026-06-10
Ingested
2026-08-22
Record hash
6b914527d51f54f0

Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.